Patients affected by hidradenitis suppurativa (HS) may experience clinically significant improvement from a variety of lifestyle modifications, according to a study published in Archives of Dermatological Research. Although...
Read MoreOf all variables associated with poor response of patients with hidradenitis suppurativa (HS) to the drug adalimumab, the occurrence of a flare before week 12 was associated with the highest risk of no response, according to a...
Read More
“ Hidradenitis suppurativa (HS) was once believed to be a disease limited to the skin, but...
Read MoreDuring a recent PW Podcast episode, we spoke with Ateev Mehrotra, MD, MPH, Associate Professor of Health Care Policy at Harvard Medical School; and Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical...
Read MoreA s a palliative care doctor in NYC during the beginning of the pandemic, my typical greeting response of “I’m fine” was speedily replaced with “I’m hanging in there.” It seemed slightly less false (because who’s really “fine”...
Read More
